SCM
ODT

Sio Capital Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Sio Capital Management’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-75,500
Closed -$1.45M – 108
2020
Q4 		$1.45M Sell
75,500
-59,500
-44% -$918K 0.3% 75
2020
Q3 		$1.81M Buy
+135,000
New +$3.82M 0.36% 63
2018
Q1 		– Sell
-50,000
Closed -$1.25M – 56
2017
Q4 		$1.25M Buy
+50,000
New +$1.18M 0.7% 34

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Sio Capital Management's ODT Position: Q1 2021 in Review

Sio Capital Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 75,500 shares — an estimated $1.45M sold.

Sio Capital Management first reported a position in ODT in Q4 2017 and held it in 3 quarters. The position peaked at $1.81M in Q3 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

  • Sio Capital Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Sio Capital Management sold 75,500 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $1.45M.
  • Sio Capital Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • Sio Capital Management's Odonate Therapeutics, Inc. Common Stock position peaked at $1.81M in Q3 2020.
  • 83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Sio Capital Management's 13F filing for Q1 2021, filed 14 May 2021.